PE20010239A1 - Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos - Google Patents

Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos

Info

Publication number
PE20010239A1
PE20010239A1 PE2000000447A PE0004472000A PE20010239A1 PE 20010239 A1 PE20010239 A1 PE 20010239A1 PE 2000000447 A PE2000000447 A PE 2000000447A PE 0004472000 A PE0004472000 A PE 0004472000A PE 20010239 A1 PE20010239 A1 PE 20010239A1
Authority
PE
Peru
Prior art keywords
sequence
polypeptide
amino acids
hemolysin
peptide
Prior art date
Application number
PE2000000447A
Other languages
English (en)
Inventor
Michael Panaccio
Robert G Ankenbauer
Detlef Hasse
Everett L Rosey
Original Assignee
Pfizer Prod Inc
Agriculture Victoria Serv Pty
Pig Res And Dev Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc, Agriculture Victoria Serv Pty, Pig Res And Dev Corp filed Critical Pfizer Prod Inc
Publication of PE20010239A1 publication Critical patent/PE20010239A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Abstract

SE REFIERE A UN POLIPEPTIDO INMUNOGENICO RECOMBINANTE O AISLADO QUE REACCIONA EN FORMA CRUZADA CON UN EPITOPE DE CELULA B O CELULA T DE UN POLIPEPTIDO DE HEMOLISINA DE LAWSONIA SPP DE PREFERENCIA L. INTRACELLULARIS, CAPAZ DE PRODUCIR LA PRODUCCION DE ANTICUERPOS, CONFERIR UNA RESPUESTA INMUNE PROTECTORA; INDUCIR INMUNIDAD HUMORAL; SE SELECCIONA DE a)UN PEPTIDO, OLIGOPEPTIDO, POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDOS CON 70% DE IDENTIDAD DE LA SECUENCIA SEC ID NO:1 DE 251 AMINOACIDOS O LA SECUENCIA DE AMINOACIDOS CODIFICADA POR LA SECUENCIA DE NUCLEOTIDOS QUE CODIFICA A LA HEMOLISINA DE pALK12(ATCC 207195); b)UN PEPTIDO, OLIGOPEPTIDO, POLIPEPTIDO QUE COMPRENDE UNA SECUENCIA DE AMINOACIDOS QUE TIENE POR LO MENOS 50% DE IDENTIDAD DE LA SECUENCIA CON LOS AMINOACIDOS 1 A 50 DE LA SECUENCIA SEC ID NO:1; c)UN HOMOLOGO, ANALOGO, DERIVADO QUE IMITA A UN EPITOPE DE CELULAS B O CELULAS T DE UN POLIPEPTIDO DE HEMOLISINA DE LAWSONIA SPP. SE REFIERE TAMBIEN A VACUNAS QUE COMPRENDEN ADEMAS UN SEGUNDO COMPONENTE QUE COMPRENDE UN PEPTIDO, POLIPEPTIDO O PROTEINA DE L.INTRACELLULARIS ANTIGENO TAL COMO SodC, OmpH, FlgE, AUTOLISINA; TAMBIEN SE REFIERE A UN VECTOR PARA VACUNAS, UNA MOLECULA DE ADN; UN PLASMIDO DESIGNADO pALK12
PE2000000447A 1999-05-13 2000-05-12 Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos PE20010239A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13402299P 1999-05-13 1999-05-13

Publications (1)

Publication Number Publication Date
PE20010239A1 true PE20010239A1 (es) 2001-02-28

Family

ID=22461415

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000447A PE20010239A1 (es) 1999-05-13 2000-05-12 Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos

Country Status (6)

Country Link
EP (1) EP1177213A4 (es)
AU (2) AU775323B2 (es)
CA (1) CA2372105A1 (es)
NZ (1) NZ515363A (es)
PE (1) PE20010239A1 (es)
WO (1) WO2000069906A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605696B1 (en) 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
ATE330013T1 (de) 2000-12-20 2006-07-15 Intervet Int Bv Lawsonia intracellularis impfstoff
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US20100129397A1 (en) 2006-12-11 2010-05-27 Boehringer Ingelheim Vetmedica, Inc. Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌(Lawsonia intracellularis)用疫苗
US20120321656A1 (en) * 2011-06-20 2012-12-20 Matthias Rath Oligopeptides and their use for treating infectious diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885823A (en) * 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
CN1145697C (zh) * 1995-11-30 2004-04-14 维多利亚农业服务控股公司 治疗和诊断组合物

Also Published As

Publication number Publication date
EP1177213A1 (en) 2002-02-06
EP1177213A4 (en) 2002-08-28
CA2372105A1 (en) 2000-11-23
AU2004224903A1 (en) 2004-11-25
AU4386100A (en) 2000-12-05
AU775323B2 (en) 2004-07-29
WO2000069906A1 (en) 2000-11-23
NZ515363A (en) 2003-07-25

Similar Documents

Publication Publication Date Title
EA199800973A1 (ru) Полипептид белка-106 наружной мембраны moraxella catarrhalis, последовательность гена и их применение
IL133056A (en) Polypeptide containing an immunogenic portion of an m. tuberculosis antigen, a variant thereof and pharmaceutical compositions containing same
IL152886A0 (en) B-7 related nucleic acids and polypeptides and pharmaceutical compositions containing the same
DE60332645D1 (de) Ii-key/antigene epitop-hybrid-peptid-vakzine
BR9306820A (pt) Conjugado de um antígeno fracamente imunogênico e um veículo peptideo sintetico vacina processos para melhorar a imunogenicidade de uma molecula de antigeno fracamente imunogenico e para imunizar um hospedeiro mamífero
AR047345A1 (es) Vacuna para mejorar el crecimiento de animales a base de epitopos neutralizantes
AR062300A2 (es) Polipeptido que comprende una porcion inmunogenica de una proteina de prostata o su variante, molecula de adn, vector de expresion, celula huesped composicion farmaceutica, vacuna uso de dichas composiciones y vacunas para preparar medicamentos y proteina de fusion
ES2157060T3 (es) Sistema de expresion de antigenos heterologos como proteinas de fusion.
ATE366313T1 (de) Antigene peptide aus neisseria
SE9402089D0 (sv) Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
WO2006116763A3 (en) Lawsonia intracellularis immunological proteins
PE20010239A1 (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos
ATE349527T1 (de) Gruppe a streptokokken-impfstoff
WO2002008716A3 (fr) Procede de criblage de peptides utilisables en immunotherapie
PE20010238A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS SodC, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS
WO2003090667A3 (fr) Composition immunogene ou vaccinale non immunosuppressive, comprenant une proteine e7 mutee du virus hpv-16
PE20010237A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS
PE20010316A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS
DE69935599D1 (de) Modifizierte hcv peptid-impfstoffe
CA2521038A1 (en) Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production
ES2079493T3 (es) Proteina de membrana externa p1 y peptidos haemophilus influenzae tipo b.
NO20011263D0 (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
WO2004056316A8 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
WO2005062871A3 (en) Tat linear epitope peptides and conjugates thereof for use in therapeutic compositions and assays
NO20006456L (no) En mutant human hepatitt B viral stamme og anvendelser derav

Legal Events

Date Code Title Description
FC Refusal